Stock listing
NASDAQ:PLRZ Polyrizon Ltd. Stock
Home listing (NASDAQ) of Polyrizon Ltd.
Follow Polyrizon Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:PLRZ
$11.26 USD +0.51 (+4.7%)
Close on Nov 2, 2026
- Day range
- $10.67 – $12.30 USDNov 2, 2026
- Volume
- 70,083 sharesNov 2, 2026
- Market cap
- $27.35M USDAt the close on Nov 2, 2026 · price × 2.43M shares outstanding
- 52-week range
- $2.88 – $18.20 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $593,666 USDMedian day 33,900 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PLRZ · Home | $11.26 USD | +0.51 (+4.7%) | 70,083 | $10.67 | $12.30 | $10.67 | $10.75 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:PLRZ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.26 | +0.51 | +4.7% | $10.67 | $12.30 | $10.67 | 70,083 | |
| $10.75 | +1.747 | +19.4% | $9.46 | $10.86 | $9.44 | 45,929 | |
| $9.003 | +0.393 | +4.6% | $8.65 | $9.003 | $8.64 | 8,189 | |
| $8.61 | +0.03 | +0.3% | $8.90 | $8.90 | $8.60 | 3,212 | |
| $8.58 | -0.377 | -4.2% | $8.968 | $8.968 | $8.54 | 5,284 | |
| $8.957 | +0.232 | +2.7% | $9.01 | $9.04 | $8.38 | 15,885 | |
| $8.725 | +0.005 | +0.1% | $8.93 | $9.37 | $8.725 | 16,200 | |
| $8.72 | -0.48 | -5.2% | $9.27 | $9.27 | $8.72 | 3,300 | |
| $9.20 | +0.05 | +0.5% | $9.242 | $9.294 | $9.20 | 7,000 | |
| $9.15 | -0.535 | -5.5% | $9.99 | $10.09 | $9.145 | 15,900 | |
| $9.685 | -0.315 | -3.1% | $9.70 | $10.37 | $9.49 | 26,500 | |
| $10.00 | -0.01 | -0.1% | $10.00 | $10.00 | $9.00 | 19,400 | |
| $10.01 | -0.40 | -3.8% | $10.31 | $10.68 | $9.80 | 73,300 | |
| $10.41 | +0.67 | +6.9% | $10.09 | $11.58 | $9.54 | 90,200 | |
| $9.74 | +0.69 | +7.6% | $9.16 | $10.00 | $8.00 | 47,000 | |
| $9.05 | +0.062 | +0.7% | $9.05 | $9.14 | $8.76 | 6,400 | |
| $8.988 | +0.118 | +1.3% | $8.67 | $9.51 | $8.22 | 40,100 | |
| $8.87 | -0.28 | -3.1% | $9.31 | $9.31 | $8.70 | 10,300 | |
| $9.15 | -0.52 | -5.4% | $9.275 | $9.275 | $9.00 | 5,100 | |
| $9.67 | +0.41 | +4.4% | $9.50 | $9.67 | $9.26 | 6,200 | |
| $9.26 | -0.35 | -3.6% | $9.48 | $9.88 | $9.129 | 17,000 | |
| $9.61 | -0.71 | -6.9% | $10.56 | $10.87 | $9.15 | 56,500 | |
| $10.32 | -0.463 | -4.3% | $10.30 | $10.48 | $10.17 | 2,000 | |
| $10.78 | +0.293 | +2.8% | $10.39 | $10.87 | $10.08 | 13,500 | |
| $10.49 | +0.13 | +1.3% | $10.61 | $11.00 | $10.36 | 8,700 | |
| $10.36 | -0.415 | -3.9% | $10.50 | $10.76 | $10.36 | 4,500 | |
| $10.78 | +0.265 | +2.5% | $10.50 | $10.78 | $10.50 | 1,000 | |
| $10.51 | -0.65 | -5.8% | $10.93 | $11.35 | $10.50 | 13,400 | |
| $11.16 | +0.50 | +4.7% | $10.62 | $11.99 | $10.09 | 40,100 | |
| $10.66 | -0.24 | -2.2% | $11.03 | $11.03 | $10.50 | 6,500 | |
| $10.90 | -0.09 | -0.8% | $11.00 | $11.00 | $10.55 | 14,800 | |
| $10.99 | -0.04 | -0.4% | $11.01 | $11.07 | $10.36 | 32,000 | |
| $11.03 | +0.38 | +3.6% | $11.60 | $11.60 | $9.15 | 159,400 | |
| $10.65 | -0.74 | -6.5% | $11.31 | $11.80 | $10.61 | 12,100 | |
| $11.39 | +0.07 | +0.6% | $11.10 | $11.39 | $10.96 | 2,100 | |
| $11.32 | +0.29 | +2.6% | $10.99 | $11.53 | $10.63 | 69,300 | |
| $11.03 | -0.20 | -1.8% | $11.19 | $11.36 | $10.50 | 76,600 | |
| $11.23 | +0.48 | +4.5% | $10.65 | $11.28 | $10.42 | 43,800 | |
| $10.75 | -0.40 | -3.6% | $11.25 | $11.25 | $10.32 | 75,400 | |
| $11.15 | -0.09 | -0.8% | $11.08 | $11.85 | $10.99 | 164,200 | |
| $11.24 | -1.32 | -10.5% | $12.40 | $12.72 | $11.00 | 141,300 | |
| $12.56 | +0.05 | +0.4% | $12.00 | $13.28 | $11.95 | 134,400 | |
| $12.51 | -1.85 | -12.9% | $14.08 | $14.96 | $12.51 | 133,700 | |
| $14.36 | -0.15 | -1.0% | $14.32 | $15.34 | $13.71 | 276,200 | |
| $14.51 | +1.365 | +10.4% | $13.00 | $14.90 | $13.00 | 45,000 | |
| $13.15 | +0.345 | +2.7% | $12.70 | $13.29 | $12.22 | 96,400 | |
| $12.80 | +1.14 | +9.8% | $11.53 | $12.99 | $11.37 | 24,000 | |
| $11.66 | +0.76 | +7.0% | $10.89 | $11.84 | $10.89 | 41,700 | |
| $10.90 | +0.20 | +1.9% | $10.47 | $11.04 | $10.22 | 42,740 | |
| $10.70 | +0.40 | +3.9% | $10.75 | $10.75 | $9.70 | 39,309 | |
| $10.30 | -0.19 | -1.8% | $10.86 | $10.86 | $10.25 | 23,200 | |
| $10.49 | -0.70 | -6.3% | $11.50 | $12.00 | $10.26 | 100,900 | |
| $11.19 | +0.83 | +8.0% | $10.28 | $11.19 | $9.80 | 79,500 | |
| $10.36 | -0.62 | -5.6% | $10.92 | $11.25 | $9.90 | 284,400 | |
| $10.98 | 0.00 | 0.0% | $10.98 | $11.27 | $10.22 | 59,200 | |
| $10.98 | +0.23 | +2.1% | $10.68 | $11.00 | $10.31 | 63,700 | |
| $10.75 | +1.03 | +10.6% | $9.70 | $11.25 | $9.69 | 79,900 | |
| $9.72 | -0.47 | -4.6% | $10.13 | $11.12 | $9.124 | 33,900 | |
| $10.19 | -1.14 | -10.1% | $11.14 | $11.66 | $9.85 | 45,300 | |
| $11.33 | -0.26 | -2.2% | $11.24 | $11.59 | $11.00 | 5,400 | |
| $11.59 | +0.10 | +0.9% | $11.44 | $12.20 | $11.02 | 11,700 | |
| $11.49 | +0.24 | +2.1% | $11.17 | $12.04 | $11.17 | 12,700 | |
| $11.25 | +1.05 | +10.3% | $10.20 | $12.10 | $10.20 | 27,100 | |
| $10.20 | -0.39 | -3.7% | $10.61 | $11.64 | $9.51 | 222,900 | |
| $10.59 | -0.66 | -5.9% | $11.25 | $11.88 | $10.30 | 95,400 |
- Ticker
- NASDAQ:PLRZ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker
Latest news
Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker
Oct 27, 2026
Closed $8.58 (-4.2%) on Oct 27, 2026
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
Oct 5, 2026
Closed $9.26 (-3.6%) on Oct 5, 2026
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Sep 22, 2026
Closed $10.66 (-2.2%) on Sep 22, 2026
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Sep 4, 2026
Closed $11.24 (-10.5%) on Sep 4, 2026
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Sep 3, 2026
Closed $12.56 (+0.4%) on Sep 3, 2026
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
Sep 2, 2026
Closed $12.51 (-12.9%) on Sep 2, 2026
Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
Aug 20, 2026
Closed $10.49 (-6.3%) on Aug 20, 2026
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
Jul 2, 2026
Closed $13.80 (+8.8%) on Jul 2, 2026
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
Jun 29, 2026
Closed $12.75 (+11.1%) on Jun 29, 2026
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform
Jun 17, 2026
Closed $13.23 (+15.5%) on Jun 17, 2026
Financings
Registered direct offering of ordinary shares and pre-funded warrants
Sep 4, 2026
Closed: US$12 a share · Aegis Capital Corp.
Dealers: Aegis Capital Corp. (lead)
Use of proceeds: General corporate purposes and working capital
Private placement of pIPE pre-funded warrants and common warrants
Sep 4, 2026
Closed: Warrants at US$12 · Aegis Capital Corp.
Dealers: Aegis Capital Corp. (lead)
Use of proceeds: General corporate purposes and working capital
Polyrizon Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 70 in all · newest Oct 27, 2026 · oldest 2024
Where Polyrizon Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PLRZ · Home listing · This page | NASDAQ | United States | USD |
| BOATS:PLRZ | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Polyrizon Ltd.